This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gruenenthal Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Rasoul Sedaghat Kerdar: Innovator in Transdermal Drug Delivery
Introduction
Rasoul Sedaghat Kerdar is a notable inventor based in Nürnberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative plaster technology aimed at reducing skin irritation during transdermal drug delivery.
Latest Patents
Kerdar holds a patent for a plaster that causes reduced skin irritation. This plaster contains an active ingredient for the transdermal administration of a pharmaceutical active ingredient. It features a removable protective film and an adhesive layer. The unique aspect of this plaster is that it includes at least one compound that can be applied to the skin to minimize irritation, enhancing patient comfort and compliance.
Career Highlights
Throughout his career, Rasoul Sedaghat Kerdar has worked with prominent companies in the pharmaceutical industry, including Grünenthal GmbH. His work has focused on improving drug delivery systems, which has the potential to benefit many patients requiring transdermal therapies.
Collaborations
Kerdar has collaborated with esteemed colleagues such as Heinrich Kugelmann and Johannes Bartholomäus. These partnerships have likely contributed to the innovative advancements in his research and development efforts.
Conclusion
Rasoul Sedaghat Kerdar's contributions to the field of transdermal drug delivery through his patented plaster technology demonstrate his commitment to improving patient care. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
